Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.
Alffenaar
J W C
JW
de Vries
P M
PM
Luijckx
G J
GJ
van Soolingen
D
D
van der Werf
T S
TS
van Altena
R
R
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D019540:Area Under Curve; D001372:Aza Compounds / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D016903:Drug Monitoring; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D000077266:Moxifloxacin; D011804:Quinolines / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D014390:Tuberculosis, Meningeal / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin